老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

enVVeno Medical Corp.

0.3656
-0.0544-12.95%
盘后：0.39630.0307+8.40%18:22 EST
成交量：287.54万
成交额：109.20万
市值：739.10万
市盈率：-0.34
高：0.3964
开：0.3700
低：0.3600
收：0.4200
52周最高：5.62
52周最低：0.3600
股本：2,021.62万
流通股本：1,908.56万
量比：2.24
换手率：15.07%
股息：- -
股息率：- -
每股收益(TTM):-1.0815
每股收益(LYR):-1.2728
净资产收益率：-57.19%
总资产收益率：-35.12%
市净率：0.25
市盈率(LYR):-0.29

数据加载中...

总览公司新闻资讯公告
2020/12/21

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

重要事件披露

8-K - Current report
2020/12/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/02

重要事件披露

8-K - Current report
2020/11/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/24

重要事件披露

8-K - Current report
2020/11/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/06

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/10/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/08

重要事件披露

8-K - Current report
2020/09/16

重要事件披露

8-K - Current report
2020/08/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/07

关联方拟减持公告

144 - Report of proposed sale of securities
2020/07/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals